Arthrosamid Gel Injection For Knee Osteoarthritis Pain Relief, Report Released

MSK Doctors (+4403300010048), a network of clinics offering advanced and regenerative treatments, has updated its report on Arthrosamid, explaining how this new treatment has been clinically proven to provide long-term relief from pain and stiffness caused by osteoarthritis, using only a single injection.

-- Arthrosamid is a new treatment option for individuals suffering from osteoarthritis pain and stiffness in the knees, with benefits found in recent clinical trials to last for up to 2 years, or possibly longer. MSK Doctors in London has updated an in-depth analysis of Arthrosamid to include the latest clinical trial results, and options for fast-access appointments with a specialist.

More information about Arthrosamid injections for osteoarthritis, how long each treatment can last, and options for no-referral booking with an Arthrosamid specialist can be found at https://mskdoctors.com/treatments/arthrosamid

Knee injections have been a common treatment for knee pain and stiffness for decades, however, most of these treatments are known to offer only limited and short-term benefits, usually lasting up to 6 months at best. Arthrosamid employs a similar approach to prevent pain and stiffness, but with a unique compound that can resist biodegradation in the body, allowing it to stay effective significantly longer.

In the most recent clinical trials, Arthrosamid has been shown to last for up to two years or longer after the initial treatment, without needing additional injections. Individuals treated with Arthrosamid continued to report reductions in pain, stiffness, and other symptoms throughout the trial, suggesting that Arthrosamid may be the first treatment to provide long-term, sustainable relief.

To achieve this, the report explains that Arthrosamid was developed using a traditional knee injection strategy, similar to common options such as hyaluronic acid, however, the injection contains a “non-degradable and non-resorbable hydrogel composed of 2.5% cross-linked polyacrylamide and 97.5% non-pyrogenic water.” This hydrogel helps to prevent friction, cushions the joint, and may potentially aid in the regeneration of damaged tissue.

Arthrosamid may be helpful for individuals suffering from knee pain and stiffness due to osteoarthritis or similar conditions, however consulting an experienced Arthrosamid specialist first is recommended. Prof. Paul Lee, founder of MSK Doctors, was one of the first clinicians approved to provide Arthrosamid to the public, and is still one of the most experienced.

The MSK Doctors clinic accepts new patients for consultation, diagnosis, or treatment, with no GP referral required, and no waiting list. Interested individuals can schedule their own appointments with a specialist of their choosing, from the MSK Doctors website.

An excerpt from the full report explains, “Clinical studies and real-world patient stories corroborate Arthrosamids efficacy, safety, and long-term benefits. Comparative studies have also highlighted its superior performance against traditional treatments like hyaluronic acid.”

More information about treatment duration, self-scheduling appointments, and the full report on Arthrosamid can be found at https://mskdoctors.com/treatments/arthrosamid

Contact Info:
Name: Bethan Lee
Email: Send Email
Organization: MSK Doctors
Address: MSK House London Road Silk Willoughby, Sleaford, Lincolnshire, Sleaford, England NG34 8NY, United Kingdom
Website: https://www.mskdoctors.com

Source: PressCable

Release ID: 89159575

If there are any errors, inconsistencies, or queries arising from the content contained within this press release that require attention or if you need assistance with a press release takedown, we kindly request that you inform us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our reliable team will be available to promptly respond within 8 hours, taking proactive measures to rectify any identified issues or providing guidance on the removal process. Ensuring accurate and dependable information is our top priority.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.